Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01889667 | Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus (T2DM) | PHASE2 | COMPLETED | 30 | — | — | Jun 1, 2013 | Nov 1, 2013 | Apr 15, 2015 | - | — |
| Name | Type | Description |
|---|---|---|
| ORMD-0801 Dose # 1 | DRUG | Oral Insulin Formulation |
| ORMD-0801 Dose # 2 | DRUG | Oral Insulin Formulation |
| Placebo | DRUG | Oil Capsules |